{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:41:40Z","timestamp":1782351700250,"version":"3.54.5"},"reference-count":32,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T00:00:00Z","timestamp":1124409600000},"content-version":"vor","delay-in-days":3001,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[1997,6]]},"abstract":"<jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To determine whether antioxidant therapy alters the disease process in severe early onset pre\u2010eclampsia, in support of the hypothesis that increased lipid peroxides and reactive oxygen species production play an important role in the pathogenesis of the disease.<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold> Randomised, double\u2010blind, placebo controlled trial.<\/jats:p><jats:p><jats:bold>Setting\n\t\t\t\t\t<\/jats:bold> Two tertiary care, referral hospitals in Johannesburg, South Africa.<\/jats:p><jats:p><jats:bold>Participants\n\t\t\t\t\t<\/jats:bold> Women with severe pre\u2010eclampsia diagnosed between 24 and 32 weeks of gestation.<\/jats:p><jats:p><jats:bold>Intervention\n\t\t\t\t\t<\/jats:bold> Combined antioxidant treatment with vitamin E (800 IU\/day), vitamin C (1000 mg\/day), and allopurinol (200 mg\/day).<\/jats:p><jats:p><jats:bold>Main outcome measures\n\t\t\t\t\t<\/jats:bold> Primary outcomes: 1. prolongation of pregnancy and 2. biochemical assessment of lipid peroxides and antioxidants. Secondary outcomes: data on maternal complications, side effects of treatment, infant outcomes and regular assessment of haematologic and renal parameters.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> The proportion of women delivered within 14 days in the antioxidant group was 52% (14\/27) compared with 76% (22\/29) in the placebo group (relative risk 0.68, 95% confidence interval 0.45\u20131.04). One woman in each group had eclampsia. Eleven women (42%) in the antioxidant and 16 (59%) in the placebo group required two antihypertensives for blood pressure control. Trial medications were well tolerated with few side effects. Lipid peroxide levels were not significantly altered in the antioxidant and placebo groups. Serum uric acid levels decreased and vitamin E levels increased significantly.<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> The results of this explanatory randomised trial do not encourage the routine use of antioxidants against pre\u2010eclampsia. However, further research with modified strategies such as earlier initiation of therapy or different combinations seem worthwhile.<\/jats:p>","DOI":"10.1111\/j.1471-0528.1997.tb11979.x","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T09:17:46Z","timestamp":1124443066000},"page":"689-696","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Antioxidants in the treatment of severe pre\u2010eclampsis an explanatory randomised controlled trial"],"prefix":"10.1111","volume":"104","author":[{"given":"A. Metin","family":"G\u00fclmezo\u01e7lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Justus","family":"Hofmeyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathys M. J.","family":"Oosthuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,19]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90889-O"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90665-0"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90778-3"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641959409084168"},{"key":"e_1_2_6_6_2","first-page":"598","article-title":"Free radicals, antioxidants, and human disease: where are we now","volume":"119","author":"Halliwell B","year":"1992","journal-title":"J Lab Clin Med"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)93024-5"},{"key":"e_1_2_6_8_2","first-page":"777","volume-title":"Maternal Fetal Medicine: Principles and Practice","author":"Roberts JM.","year":"1989"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.1990.tb03246.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01805810"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198707093170209"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.102.2.556"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1542\/peds.85.6.961","article-title":"Current and potentially new management strategies for perinatal hypoxic\u2010ischemic encephalopathy","volume":"85","author":"Vannucci RC.","year":"1990","journal-title":"Pediatrics"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199306000-00018"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348909009902"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)91102-I"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1994.tb11940.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(05)80410-6"},{"key":"e_1_2_6_19_2","article-title":"Lipid peroxidation in eclampsia","author":"G\u00fclmezoglu AM","year":"1997","journal-title":"J Obstet Gynaecol"},{"key":"e_1_2_6_20_2","first-page":"1070","article-title":"Aggressive or expectant management for patients with severe preeclampsia between 28\u201334 weeks' gestation: A randomized controlled trial","volume":"76","author":"Odendaal HJ","year":"1990","journal-title":"Obstet Gynecol"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-199235020-00023"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(79)90738-3"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/clinchem\/31.6.880","article-title":"Determination of vitamin E in microsamples of serum by liquid chromatography with electrochemical detection","volume":"31","author":"Chou PP","year":"1985","journal-title":"Clin Chem"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641959609009589"},{"key":"e_1_2_6_25_2","first-page":"626","article-title":"Conservative management of severe preeclampsia remote from term","volume":"84","author":"Schiff E","year":"1994","journal-title":"Obstet Gynecol"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(93)90032-8"},{"key":"e_1_2_6_27_2","first-page":"584","article-title":"Expectant management of early onset severe pre\u2010eclampsia in Durban","volume":"83","author":"Moodley J","year":"1993","journal-title":"S Afr Med J"},{"key":"e_1_2_6_28_2","first-page":"516","article-title":"Conservative management of severe proteinuric hypertension before 28 weeks' gestation","volume":"73","author":"Pattinson RC","year":"1988","journal-title":"S Afr Med J"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"1061S","DOI":"10.1093\/ajcn\/53.4.1061S","article-title":"Effect of smoking and vitamin E on blood antioxidant status","volume":"53","author":"Duthie GG","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/ajcn\/60.3.383","article-title":"Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged","volume":"60","author":"Brown KM","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(91)90017-L"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1994.tb13146.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90172-8"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.1997.tb11979.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.1997.tb11979.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T21:10:06Z","timestamp":1698441006000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.1997.tb11979.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["10.1111\/j.1471-0528.1997.tb11979.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.1997.tb11979.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6]]},"assertion":[{"value":"2005-08-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}